AbstractIntroductionThis study examined whether, among subjects with mild cognitive impairment (MCI), women progressed at faster rates than men.MethodsWe examine longitudinal rates of change from baseline in 398 MCI subjects (141 females and 257 males) in the Alzheimer's Disease Neuroimaging Initiative-1, followed for up to 8 years (mean, 4.1 ± 2.5 years) using mixed-effects models incorporating all follow-ups (mean, 8 ± 4 visits).ResultsWomen progressed at faster rates than men on the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog; P = .001) and clinical dementia rating-sum of boxes (CDR-SB; P = .003). Quadratic fit for change over time was significant for both ADAS-Cog (P = .001) and CDR-SB (P = .004), and the additiona...
This is the author accepted manuscript. The final version is available from IOS Press via the DOI in...
Objectives: To investigate the interaction effect of sex and early vs. late onset of Alzheimer’s dis...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting cognition, daily func...
AbstractIntroductionThis study examined whether, among subjects with mild cognitive impairment (MCI)...
Sex differences in Alzheimer’s disease (AD) biology and progression are not yet fully characterized....
© 2018, © 2018 Taylor & Francis. This study examined biological sex differences in the development...
Sex differences in Alzheimer's disease (AD) biology and progression are not yet fully characterized....
Background: While the gender/sex differences in neuropsychiatric symptoms in dementia population are...
ObjectiveTo examine sex differences in the relationship between clinical symptoms related to Alzheim...
Objective: To examine sex differences in the relationship between clinical symptoms related to Alzhe...
International audienceOBJECTIVE: To examine risk factors for mild cognitive impairment (MCI) and pro...
Background: While the gender/sex differences in neuropsychiatric symptoms in dementia population are...
International audienceOBJECTIVE: To examine risk factors for mild cognitive impairment (MCI) and pro...
Background: While the gender/sex differences in neuropsychiatric symptoms in dementia population are...
International audienceOBJECTIVE: To examine risk factors for mild cognitive impairment (MCI) and pro...
This is the author accepted manuscript. The final version is available from IOS Press via the DOI in...
Objectives: To investigate the interaction effect of sex and early vs. late onset of Alzheimer’s dis...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting cognition, daily func...
AbstractIntroductionThis study examined whether, among subjects with mild cognitive impairment (MCI)...
Sex differences in Alzheimer’s disease (AD) biology and progression are not yet fully characterized....
© 2018, © 2018 Taylor & Francis. This study examined biological sex differences in the development...
Sex differences in Alzheimer's disease (AD) biology and progression are not yet fully characterized....
Background: While the gender/sex differences in neuropsychiatric symptoms in dementia population are...
ObjectiveTo examine sex differences in the relationship between clinical symptoms related to Alzheim...
Objective: To examine sex differences in the relationship between clinical symptoms related to Alzhe...
International audienceOBJECTIVE: To examine risk factors for mild cognitive impairment (MCI) and pro...
Background: While the gender/sex differences in neuropsychiatric symptoms in dementia population are...
International audienceOBJECTIVE: To examine risk factors for mild cognitive impairment (MCI) and pro...
Background: While the gender/sex differences in neuropsychiatric symptoms in dementia population are...
International audienceOBJECTIVE: To examine risk factors for mild cognitive impairment (MCI) and pro...
This is the author accepted manuscript. The final version is available from IOS Press via the DOI in...
Objectives: To investigate the interaction effect of sex and early vs. late onset of Alzheimer’s dis...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting cognition, daily func...